Voyager Therapeutics (VYGR)
(Delayed Data from NSDQ)
$8.77 USD
-0.17 (-1.90%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $8.77 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.38 |
EPS Last Quarter | -0.20 |
Last EPS Surprise | 54.55% |
ABR | 1.20 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.39 |
Next Year | -1.56 |
EPS (TTM) | -0.05 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 11.52M | 10.77M | 52.72M | 82.20M |
# of Estimates | 4 | 4 | 4 | 3 |
High Estimate | 19.08M | 18.07M | 73.84M | 159.09M |
Low Estimate | 5.00M | 4.00M | 33.50M | 10.00M |
Year ago Sales | 4.85M | 4.61M | 250.01M | 52.72M |
Year over Year Growth Est. | 137.53% | 133.56% | -78.91% | 55.93% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.38 | -0.38 | -1.39 | -1.56 |
# of Estimates | 5 | 4 | 5 | 5 |
Most Recent Consensus | -0.31 | -0.32 | -1.13 | -1.24 |
High Estimate | -0.22 | -0.26 | -1.01 | 0.06 |
Low Estimate | -0.47 | -0.51 | -1.69 | -2.32 |
Year ago EPS | -0.51 | -0.59 | 2.97 | -1.39 |
Year over Year Growth Est. | 25.49% | 35.59% | -146.80% | -11.94% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 3 | 4 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.38 | -0.38 | -1.39 | -1.56 |
7 Days Ago | -0.38 | -0.38 | -1.39 | -1.56 |
30 Days Ago | -0.38 | -0.38 | -1.39 | -1.56 |
60 Days Ago | -0.48 | -0.47 | -1.64 | -1.49 |
90 Days Ago | -0.48 | -0.47 | -1.64 | -1.49 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.38 | -0.38 | -1.39 | -1.56 |
Zacks Consensus Estimate | -0.38 | -0.38 | -1.39 | -1.56 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.20 | 1.25 | -0.59 | -0.51 | NA |
Estimate | -0.44 | -0.59 | -0.58 | -0.59 | NA |
Difference | 0.24 | 1.84 | -0.01 | 0.08 | 0.54 |
Surprise | 54.55% | 311.86% | -1.72% | 13.56% | 94.56% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more